Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC cardiovascular disorders Shiffman, D., Perez, M. V., Bare, L. A., Louie, J. Z., Arellano, A. R., Devlin, J. J. 2015; 15 (1): 104-?
View details for DOI 10.1186/s12872-015-0100-7
View details for PubMedID 26419225